Heterozygous p53-deficient (+/-) mice develop fewer p53-negative preneoplastic focal liver lesions in response to treatment with diethylnitrosamine than do wild-type (+/+) mice.

Source:http://linkedlifedata.com/resource/pubmed/id/15072823

Cancer Lett. 2004 Apr 30 207 2 149-55

Download in:

View as

General Info

PMID
15072823